UltraGreen.ai Limited (SGX:ULG)

Singapore flag Singapore · Delayed Price · Currency is SGD · Price in USD
1.580
+0.050 (3.27%)
At close: Mar 20, 2026
Market Cap2.23B
Revenue (ttm)177.43M +20.3%
Net Income97.27M +35.2%
EPS0.25 -99.8%
Shares Out1.10B
PE Ratio12.02
Forward PE20.79
Dividendn/a
Ex-Dividend Daten/a
Volume2,914,200
Average Volume2,338,600
Open1.540
Previous Close1.530
Day's Range1.510 - 1.600
52-Week Range1.310 - 1.860
Betan/a
RSI48.64
Earnings DateFeb 26, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2024
Employees 93
Stock Exchange Singapore Exchange
Ticker Symbol ULG
Full Company Profile

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 20.26% compared to the previous year's $114.71 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD Financial Statements